Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.
Conference Paper
Full Text
Duke Authors
Cited Authors
- Verschraegen, CF; Vincent, M; Abbruzzese, JL; Siegler, D; Kavanagh, JJ; Loyer, E; Kudelka, AP; Rubin, E
Published Date
- 2000
Published In
Volume / Issue
- 922 /
Start / End Page
- 345 - 348
PubMed ID
- 11193919
International Standard Serial Number (ISSN)
- 0077-8923
Digital Object Identifier (DOI)
- 10.1111/j.1749-6632.2000.tb07061.x
Conference Location
- United States